tryz Wow Im no SEC Attorney but I think Ironridge had some

New Post Public Reply Private Reply Replies (1) Message Board
Tutter18 tryz #7245
tryz Wow Im no SEC Attorney but I think Ironridge had some bad news today and maybe just maybe could be good news for Scripsamerica ans alot of other companies! Go SCRC! Tut

see link http://www.sec.gov/litigation/admin/2015/34-75272.pdf

Ironridge Global Partners, LLC and Ironridge Global IV, Ltd.

.

06/23/2015 02:30 PM EDT

The Securities and Exchange Commission (“Commission”) deems it appropriate
and in the public interest that public administrative and cease-and-desist proceedings be,
and hereby are, instituted pursuant to Sections 15(b) and 21C of the Securities Exchange
Act of 1934 (“Exchange Act”) against Ironridge Global Partners, LLC (“Ironridge”) and
Ironridge Global IV, Ltd. (“Global IV”) (collectively referred to as “Respondents”).
II.
After an investigation, the Division of Enforcement alleges that:
Summary
1. This matter involves violations of the broker-dealer registration
provisions by Ironridge Global IV, Ltd. (“Global IV”), a British Virgin Islands business
company, and its formerly San Francisco, California-based parent company, Ironridge
Global Partners, LLC (“Ironridge”). Between April 2011 through March 2014, Ironridge
willfully violated Sections 15(a) and 20(b) of the Securities Exchange Act of 1934
(“Exchange Act”), and Global IV willfully violated Section 15(a) of the Exchange Act
through Global IV’s operation as an unregistered dealer by engaging in serial
underwriting activity, providing related investment advice, and receiving and selling 2
billions of shares in connection with self-described financing services for domestic
microcap stock companies (“microcap issuers”) explicitly designed to utilize the
registration exemption contained in Section 3(a)(10) of the Securities Act of 1933
(“Securities Act”). In relevant part, Section 3(a)(10) of the Securities Act exempts from
registration securities issued in court-approved exchanges for “bona fide outstanding
claims.” As part of its business model, Ironridge designed and openly promoted a
“liabilities for equity” or “LIFE” financing program, through which Ironridge arranged to
have Global IV purchase outstanding claims from microcap issuers’ creditors and then
settle those claims through Section 3(a)(10) exchanges. Under the resulting settlements,
Global IV received steeply discounted shares, which Global IV subsequently sold at the
direction of Ironridge’s principals. Between April 2011 and March 26, 2014, at the
direction of Ironridge, Global IV engaged in 33 separate Section 3(a)(10) exchanges with
28 microcap issuers. During this period, Global IV received and sold approximately 5.5
billion shares of the issuers’ common stock, thereby realizing proceeds of approximately
$56 million and net profits of approximately $22 million. Since March 2014, Ironridge
has continued to promote its LIFE program, and Global IV has continued to receive and
sell shares pursuant to Section 3(a)(10) exchanges.
Respondents
2. Ironridge Global Partners, LLC (“Ironridge”) is a Delaware limited
liability company. Prior to July 2014, Ironridge’s principal place of business was in San
Francisco, California. Ironridge has four principals (“Ironridge principals” or “Ironridge’s
principals”), all of whom are natural persons who reside in the United States and are United
States citizens. Until January 2015, Ironridge was the sole shareholder in Ironridge Global
IV, Ltd. Ironridge is not registered with the Commission in any capacity.
3. Ironridge Global IV, Ltd. (“Global IV”) is a British Virgin Islands
business company with its principal place of business in the British Virgin Islands. Global
IV was a wholly owned subsidiary of Ironridge prior to January 2015, and is not registered
with the Commission in any capacity.
4. Prior to November 30, 2012, three of the five directors of Global IV
were Ironridge principals.
5. Although the three Ironridge principals resigned as Global IV
directors in November 2012, under Global IV’s “Amended & Restated Articles of
Association,” Ironridge, as the former sole shareholder of Global IV, had the power to
remove the directors of Global IV with or without cause, and without notice.
6. On behalf of Ironridge, Ironridge’s principals thus exercised control
of Global IV. 3
Ironridge Develops a Finance Model Based on the Registration Exemption
Contained in Section 3(a)(10) of the Securities Act
7. In relevant part, Section 3(a)(10) of the Securities Act provides an
exemption from registration for securities issued in exchange for bona fide outstanding
claims approved by any court or other authorized body after a fairness hearing is
conducted.
8. Since its formation, Ironridge has marketed itself as a source of
innovative financing solutions for microcap issuers.
9. In particular, one of Ironridge’s principals designed a finance model
whereby Global IV would purchase outstanding claims against microcap issuers and then
settle those claims through Section 3(a)(10) exchanges.
10. Ironridge named this finance model the “Liability for Equity (LIFE)
program,”(the “LIFE program”) and touted it as an “innovative financing structure” on its
website and in certain business and finance publications.
Ironridge’s Solicitation of, and Negotiations with Microcap Issuers and Their
Creditors
11. From approximately April 2011 through March 2014 (“the relevant
period”), Ironridge identified and contacted certain microcap issuers as potential candidates
for financing through Section 3(a)(10) exchanges on behalf of Global IV.
12. In some instances, with Ironridge’s authorization, Global IV paid
registered broker-dealers and other persons commissions for related referral services.
13. Ironridge’s principals advised the microcap issuers as to the
structure and purported benefits of the contemplated Section 3(a)(10) exchanges on behalf
of Global IV.
14. Ironridge negotiated the terms of the transaction with the microcap
issuers and drafted the term sheet executed by the microcap issuers on behalf of Global IV.
15. Additionally, certain of Ironridge’s principals advised and assisted
microcap issuers in identifying various creditor claims (e.g., inventory suppliers and law
firm bills) for a possible purchase by Global IV.
16. After identifying creditor claims to be included in a contemplated
Section 3(a)(10) exchange, and with the consent of the microcap issuers, certain of
Ironridge’s principals then negotiated directly with the creditors for the purchase of the
claims by Global IV. 4
17. Global IV purchased the claims of certain creditors of microcap
issuers participating in its LIFE program through a Receivable Purchase Agreement
(“RPA”) executed separately with each such creditor.
18. Pursuant to the terms of the RPA, Global IV typically agreed to pay
each creditor for the entire amount of the debt owed by the microcap issuer, typically on a
payment schedule that calls for several monthly payments in exchange for an immediate
assignment of the rights, title, and interest in the underlying claim.
19. Certain of Ironridge’s principals contacted the issuer’s creditors,
directly negotiated the terms of the associated RPAs on behalf of Global IV with these
creditors , and directed Global IV to execute the RPAs.
Issuance of Unrestricted Stock to Global IV
Through Section 3(a)(10) Exchanges
20. During the relevant period, after Global IV was assigned claims
against a particular microcap issuer, it filed suit (styled as a collection action for breach of
contract) against the microcap issuer in California state court.
21. Through related “fairness hearings,” the court approved the terms of
related settlement agreements through which Global IV would be issued unrestricted stock
in exchange for extinguishing its claims against the microcap stock companies participating
in the LIFE program.
22. The court-approved settlement agreements provided Global IV with
an initial issuance of shares subject to adjustment based on the operation of a price
protection formula.
23. Pursuant to the price protection formulas contained in the settlement
agreements, Global IV was entitled to receive additional shares at a discount if the
microcap issuers’ share prices declined during specified periods following court approval
of the exchanges.
Global IV’s Sale of Shares Issued in Section 3(a)(10) Exchanges
24. During the relevant period, Global IV engaged in 33 separate
Section 3(a)(10) exchanges with 28 microcap issuers. In connection with underlying
claims totaling approximately $35 million, Global IV sold approximately 5.5 billion
shares of the issuers’ stock for total proceeds of approximately $56 million, thereby
realizing a profit of approximately $22 million.
25. As a result of Global IV’s Section 3(a)(10) transactions during the
relevant period, the public float of shares for many of the issuers increased significantly.
For 14 of the issuers, the Section 3(a)(10) transactions increased the shares outstanding5
by 25% or more. For nine of these issuers, the transactions increased the shares
outstanding by at least 50%.
26. On average, Global IV began selling the initial shares that it
received from the 33 Section 3(a)(10) exchanges at issue within four trading days of the
shares being cleared for trading.
27. Global IV continued to sell the microcap issuers’ shares through the
applicable Calculation Period.
28. Global IV’s sales frequently represented a significant percentage of
the total daily trading volume for the issuer’s shares.
29. In six of the 33 Section 3(a)(10) transactions at issue, Global IV’s
sale of shares on certain days represented 100% of the total daily trading volume for that
security.
30. For 15 of the 33 Section 3(a)(10) transactions at issue, Global IV’s
sales represented 90% or more of the total daily trading volume for that security on certain
days.

Mechanics of Global IV’s Stock Sales
31. Global IV deposited the stock issued through the Section 3(a)(10)
exchanges in various domestic and foreign brokerage accounts held by Global IV.
32. Certain of Ironridge’s principals had trading authority over Global
IV’s brokerage accounts and thus controlled or directed the deposit of stock into those
accounts.
33. Thereafter, Global IV sold stock obtained through Section 3(a)(10)
exchanges in the open market.
34. Certain of Ironridge’s principals had trading authority over Global
IV’s brokerage accounts and thus controlled or directed Global IV’s sale of shares from
those accounts.
35. Global IV’s sale of the shares that it received from the microcap
issuers through Section 3(a)(10) exchanges typically drove down the share price and
increased the number of shares that Global IV received under the applicable price
protection formulas.
36. At times, Ironridge directed microcap issuers participating in the
LIFE program to issue additional shares to Global IV pursuant to the price protection
formulas contained in their respective settleme

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 20

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 58

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 0

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 138

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

BD Settles SEC Investigation While Strengthening Operations

Updated Category News Views 215

BD Reaches Settlement with the SEC BD (Becton, Dickinson and Company) (NYSE: BDX), a renowned leader in medical technology, has announced a significant agreement to resolve an investigation by the U.S. Securities and Exchange Commission (SEC). This follows concerns regarding prior public disclosures related to the BD Alaris™ System. Key Details of the Resolution The...

Continue Reading
Seizing the Managed Detection and Response Market Opportunity

Updated Category News Views 232

Unlocking the Managed Detection and Response Market Potential Middleton, Massachusetts – QKS Group, a leading market intelligence and advisory firm, recently released an insightful report on the global Managed Detection and Response (MDR) Market. This comprehensive analysis targets industry leaders eager to tap into a rapidly growing sector. According to their findings,...

Continue Reading
Expanding Horizons: Coldwell Banker's Venture into Africa

Updated Category News Views 94

Coldwell Banker Real Estate's New Milestone Coldwell Banker Tanzania and Zanzibar have officially joined the growing network of Coldwell Banker Real Estate LLC, marking an exciting expansion into Africa. This new master franchise embodies the brand’s ongoing commitment to deliver top-tier real estate services on an international scale. Seizing Growing Markets The real...

Continue Reading
Automotive Grade Linux Unveils SoDeV Platform for Advancements

Updated Category News Views 289

Automotive Grade Linux Introduces SoDeV for Software Defined Vehicles In an exciting development for the automotive industry, Automotive Grade Linux (AGL) has launched SoDeV, an open-source reference platform aimed at significantly enhancing the development of Software Defined Vehicles (SDVs). This innovative platform allows developers to focus on software-first...

Continue Reading
Exploring Promising Tech Stocks Ahead of Future Opportunities

Updated Category News Views 257

Opportunity in Oversold Tech Stocks The information technology sector is witnessing a notable shift, with several stocks currently considered undervalued. These oversold stocks represent potential opportunities for savvy investors looking to capitalize on future growth. By focusing on these stocks, investors can identify undervalued companies that have the potential for...

Continue Reading